IMNP
Immune Pharmaceuticals Inc.
IMNP
IMNP
Delisted
IMNP was delisted on the 25th of July, 2018.
15 hedge funds and large institutions have $483K invested in Immune Pharmaceuticals Inc. in 2015 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$54K | |
| 2 | +$53.9K | |
| 3 | +$32K | |
| 4 |
Goldman Sachs
New York
|
+$2.96K |
Top Sellers
| 1 | -$27K | |
| 2 | -$24.9K | |
| 3 | -$18K | |
| 4 |
BPCE
Bank Pictet & Cie (Europe)
Frankfurt Am Main,
Germany
|
-$15K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$5.67K |